Horizon Therapeutics Publ...

AI Score

XX

Unlock

116.30
0.00 (0.00%)
At close: Jan 16, 2025, 9:00 PM
0.00%
Bid n/a
Market Cap 26.6B
Revenue (ttm) n/a
Net Income (ttm) 0
EPS (ttm) 1.88
PE Ratio (ttm) 61.86
Forward PE n/a
Analyst n/a
Ask n/a
Volume 23,917,757
Avg. Volume (20D) 0
Open 116.34
Previous Close 116.30
Day's Range 116.30 - 116.34
52-Week Range 116.30 - 116.34
Beta 1.01

About HZNP

Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-...

Sector Healthcare
IPO Date Jul 28, 2011
Employees 2,190
Stock Exchange NASDAQ
Ticker Symbol HZNP
Full Company Profile
No News article available yet